SureCare Forms Strategic Relationship With Abbott; Company To Lead Market New Advanced...

Business Editors & Health/Medical Writers

HOUSTON--(BW HealthWire)--July 29, 2002

SureCare Inc. (OTC BB:SURC), a leading provider in distributed healthcare, today announced the expansion of its relationship with Abbott Laboratories (NYSE:ABT), a global, broad-based health

Abbott employs approximately 70,000 people worldwide, and markets its products in more than 130 countries.

SureCare will lead market Abbott's new advanced technology product, Medisense Optium meter and test strips, to its diabetes client base including managed care and government payers. Pursuant to the terms of The Mail Order Supply Agreement, SureCare was awarded a purchase line of credit to help facilitate growth as it aggressively markets Optium as a preferred diabetes testing product. Optium possess several important user features including biosensor technology for smaller sample size, download capability for tracking, date and time stamp, large display, individually wrapped strips for protection and a meter which does not require cleaning - all which are significant for diabetes patient care. Abbott has limited its contracting for Optium during the product launch period, and SureCare was selected as one of the preferred companies to be offered an agreement.

"We are very pleased to have a strategic relationship with Abbott that is supported by a purchase line of credit. We also see great benefits with the mail order only distribution method for Optium which facilitates our regular interaction with members in support of their diabetes self management plan. This enhanced relationship should result in improved client retention and financial performance as we penetrate the market with this product" stated Grant Gables, President.

Terry McDonald RRT, Vice President of Operations and Clinical Development, added, "Access to the Optium product provides SureCare and its members with several important benefits. After conducting several focus group studies with Abbott, we believe Optium will be very well received by our members with diabetes due to enhanced features and ease of use."

SureCare (www.surecare.md), is a growing distributed healthcare company that provides cost savings to healthcare organizations. Distributed healthcare is a disease-focused linkage of goods distribution with consumer education and experience, while collecting and distributing important clinical outcomes data. By providing high quality healthcare resources to the consumer, SureCare seeks to reduce the cost of chronic diseases while improving the consumers' experience. SureCare is also licensed as a durable medical equipment provider for both the Medicare and Medicaid programs, and has recently received licensure as a pharmacy in the State of Texas.

This press release contains certain forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the Securities and Exchange Act of 1934. Investors are cautioned that all statements included in this press release which are not historical fact, are forward-looking statements. Although the Company believes that forward-looking statements contained herein are reasonable, there can be no assurance that the forward-looking statements included herein will be correct or accurate. The inclusion of such information should not be regarded as a representation by the Company or any other person that the objectives and plans of the Company will be achieved.